K
Kevin Outterson
Researcher at Boston University
Publications - 130
Citations - 6308
Kevin Outterson is an academic researcher from Boston University. The author has contributed to research in topics: Public health & Incentive. The author has an hindex of 28, co-authored 126 publications receiving 4074 citations. Previous affiliations of Kevin Outterson include West Virginia University & West Virginia University College of Law.
Papers
More filters
Journal ArticleDOI
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Evelina Tacconelli,Elena Carrara,Alessia Savoldi,Stéphan Juergen Harbarth,Marc Mendelson,Dominique L Monnet,Céline Pulcini,Gunnar Kahlmeter,Jan Kluytmans,Yehuda Carmeli,Marc Ouellette,Kevin Outterson,Jean B. Patel,Marco Cavaleri,Edward Cox,Christopher R. Houchens,M Lindsay Grayson,Paul Hansen,Nalini Singh,Ursula Theuretzbacher,Nicola Magrini,Aaron O. Aboderin,Seif Al-Abri,Nordiah Awang Jalil,Nur Benzonana,Sanjay Bhattacharya,Adrian Brink,Francesco Robert Burkert,Otto Cars,Giuseppe Cornaglia,Oliver J. Dyar,Alexander W. Friedrich,Ana Cristina Gales,Sumanth Gandra,Christian G. Giske,Debra A. Goff,Herman Goossens,Thomas Gottlieb,Manuel Guzman Blanco,Waleria Hryniewicz,Deepthi Kattula,Timothy Jinks,Souha S. Kanj,Lawrence Kerr,Marie-Paule Kieny,Yang Soo Kim,Roman S. Kozlov,Jaime Labarca,Ramanan Laxminarayan,Karin Leder,Leonard Leibovici,Gabriel Levy-Hara,Jasper Littman,Surbhi Malhotra-Kumar,Vikas Manchanda,Lorenzo Moja,Babacar Ndoye,Angelo Pan,David L. Paterson,Mical Paul,Haibo Qiu,Pilar Ramon-Pardo,Jesús Rodríguez-Baño,Maurizio Sanguinetti,Sharmila Sengupta,Mike Sharland,Massinissa Si-Mehand,Lynn L. Silver,Wonkeung Song,Martin Steinbakk,Jens Thomsen,Guy E. Thwaites,Jos W. M. van der Meer,Nguyen Van Kinh,Silvio Vega,Maria Virginia Villegas,Agnes Wechsler-Fördös,Heiman F. L. Wertheim,Evelyn Wesangula,Neil Woodford,Fidan O Yilmaz,Anna Zorzet +81 more
TL;DR: Future development strategies should focus on antibiotics that are active against multidrug-resistant tuberculosis and Gram-negative bacteria, and include antibiotic-resistant bacteria responsible for community-acquired infections.
Journal ArticleDOI
The global preclinical antibacterial pipeline.
TL;DR: The innovative potential of the preclinical pipeline compared with the clinical pipeline is encouraging but fragile and much more work, focus and funding are needed for the novel approaches to result in effective antibacterial therapies to sustainably combat antibacterial resistance.
Journal ArticleDOI
Antibiotic development — economic, regulatory and societal challenges
Christine Årdal,Manica Balasegaram,Ramanan Laxminarayan,David McAdams,Kevin Outterson,John H. Rex,Nithima Sumpradit +6 more
TL;DR: The challenges that are contributing to the decline in antibiotic drug discovery and development, and the international and national initiatives aimed at incentivizing research and the development of new antibiotics to improve the economic feasibility of antibiotic development are discussed.
Journal ArticleDOI
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later
Ramanan Laxminarayan,Thomas P. Van Boeckel,Isabel Frost,Samuel Kariuki,Ejaz Ahmad Khan,Direk Limmathurotsakul,D. G. Joakim Larsson,Gabriel Levy-Hara,Marc Mendelson,Kevin Outterson,Sharon J. Peacock,Yong-Guan Zhu +11 more
TL;DR: Except for in a few leading countries, antimicrobial resistance has not captured the sustained focus of national leaders and country-level actors, including care providers.
Journal ArticleDOI
International cooperation to improve access to and sustain effectiveness of antimicrobials
Christine Årdal,Kevin Outterson,Kevin Outterson,Steven J. Hoffman,Steven J. Hoffman,Abdul Ghafur,Mike Sharland,Nisha Ranganathan,Richard D. Smith,Anna Zorzet,Jennifer Cohn,Jennifer Cohn,Didier Pittet,Didier Pittet,Nils Daulaire,Chantal M. Morel,Chantal M. Morel,Zain Rizvi,Manica Balasegaram,Osman Dar,Osman Dar,David L Heymann,David L Heymann,David L Heymann,Alison Holmes,Luke S. P. Moore,Ramanan Laxminarayan,Ramanan Laxminarayan,Ramanan Laxminarayan,Marc Mendelson,John-Arne Røttingen,John-Arne Røttingen,John-Arne Røttingen +32 more
TL;DR: In this paper, the authors call on policy makers to develop, endorse, and finance new global institutional arrangements that can ensure robust implementation and bold collective action for securing access to effective antimicrobials.